Pathogenic Study of Adult Immune Enteropathies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
About this trial
The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac disease, refractory celiac disease and other immune diseases such as monogenic enteropathy, inflammatory bowel diseases or drug induced intestinal diseases. Mechanisms of transformation of lymphocytes leading to onset of lymphomatous complications of immune enteropathies will be investigated. Mechanisms of loss of hepatic lymphocytic homeostasis will also be assessed in liver associated diseases.
Eligibility criteria
Qualifiers
18 years or over
affiliated to social insurance
signed informed consent
Disqualifiers
pregnancy
under guardianship
not able to sign informed consent
Trial design
Treatments tested in this trial
- Blood sample collection; gastrointestinal biopsy
Treatment groups
200 Participants
are divided into 7 treatment groups7
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Institut National de la Santé Et de la Recherche Médicale, France
Lead sponsor
Imagine Institute
Collaborator
Source ClinicalTrials.gov